Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI İLAÇ SANAYI VE TICARET A.Ş. Istanbul TR
02 2EGIS Pharmaceuticals PLC Budapest HU
03 2Moehs Iberica S.L. Rubi ES
04 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
05 1ARCH PHARMALABS LIMITED Mumbai IN
06 1ARENE LIFE SCIENCES PRIVATE LIMITED Hyderabad IN
07 1ARENE LIFE SCIENCES PRIVATE LIMITED Sangareddy IN
08 2AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad IN
09 1CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
10 1CHANGZHOU RUIMING PHARMACEUTICAL CO., LTD. Chunjiang Town CN
11 2CIPLA LIMITED Mumbai IN
12 1ESTEVE QUIMICA S.A. Barcelona ES
13 1Eczacibasi Özgün Kimyasal Ürünler Sanayi ve Ticaret A.S. Cerkezköy, Tekirdag TR
14 2GEDEON RICHTER PLC Budapest HU
15 1GLOCHEM INDUSTRIES LIMITED Hyderabad IN
16 3GLOCHEM INDUSTRIES PRIVATE LIMITED Hyderabad IN
17 2HETERO DRUGS LIMITED Hyderabad IN
18 2IPCA Laboratories Limited Mumbai IN
19 1KOPRAN RESEARCH LABORATORIES LIMITED Mumbai IN
20 2KRKA, d.d., Novo mesto Novo mesto SI
21 1LEK PHARMACEUTICALS D.D. Ljubljana SI
22 1LUPIN LIMITED Mumbai IN
23 1NOVARTIS PHARMA AG Basel CH
24 1ORCHID CHEMICALS & PHARMACEUTICALS LTD. Chennai IN
25 1Oman Chemicals And Pharmaceuticals L.L.C. Al Buraimi OM
26 1RAGHAVA LIFE SCIENCES PRIVATE LIMITED Hyderabad IN
27 1Smruthi Organics Limited Solapur IN
28 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
29 1TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
30 1Unichem Laboratories Limited Mumbai IN
31 2VIATRIS SPECIALTY LLC Morgantown US
32 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN
33 1ZYDUS LIFESCIENCES LIMITED Ankleshwar IN
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R1-CEP 2005-052 - Rev 05
Status : Valid
Issue Date : 2021-02-25
Type : Chemical
Substance Number : 1491
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Amlodipine Besilate, Synthesis B Process B
Certificate Number : CEP 2023-411 - Rev 00
Status : Valid
Issue Date : 2024-06-14
Type : Chemical
Substance Number : 1491
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
Certificate Number : R0-CEP 2021-359 - Rev 02
Status : Valid
Issue Date : 2023-03-23
Type : Chemical
Substance Number : 1491
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Amlodipine Besilate, Synthetic Route B
Certificate Number : R1-CEP 2007-185 - Rev 02
Status : Valid
Issue Date : 2016-12-19
Type : Chemical
Substance Number : 1491
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
Certificate Number : R1-CEP 2005-237 - Rev 02
Status : Valid
Issue Date : 2020-06-29
Type : Chemical
Substance Number : 1491
92
PharmaCompass offers a list of Amlodipine Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amlodipine Besylate manufacturer or Amlodipine Besylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amlodipine Besylate manufacturer or Amlodipine Besylate supplier.
PharmaCompass also assists you with knowing the Amlodipine Besylate API Price utilized in the formulation of products. Amlodipine Besylate API Price is not always fixed or binding as the Amlodipine Besylate Price is obtained through a variety of data sources. The Amlodipine Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate, including repackagers and relabelers. The FDA regulates benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate supplier is an individual or a company that provides benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate active pharmaceutical ingredient (API) or benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate finished formulations upon request. The benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate suppliers may include benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate API manufacturers, exporters, distributors and traders.
click here to find a list of benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate CEP of the European Pharmacopoeia monograph is often referred to as a benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Certificate of Suitability (COS). The purpose of a benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate to their clients by showing that a benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate CEP has been issued for it. The manufacturer submits a benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate CEP holder for the record. Additionally, the data presented in the benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate DMF.
A benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate suppliers with CEP (COS) on PharmaCompass.
We have 31 companies offering benzenesulfonic acid; 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Get in contact with the supplier of your choice:
